SARS-CoV-2-IN-61
SARS-CoV-2-IN-61 (compound 8i) is a SARS CoV-2 PLpro inhibitor with an IC50 of 16 µM. SARS-CoV-2-IN-61 has antiviral activities[1].
Product Specifications
CAS Number
3044004-40-9
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-61.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](NC(C1=CC(C(N(CCC)CCC)=O)=CC=C1)=O)C2=CC=CC3=CC=CC=C32
Molecular Formula
C26H30N2O2
Molecular Weight
402.53
References & Citations
[1]Arun K Ghosh, et al. SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads. Bioorg Med Chem Lett. 2023 Sep 27:96:129489.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401007 100 µg
SHP1 (PTPN6) (NM_002831) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC040833-100 1x 100 µL
Calponin-1 (CALP + CNN1/832), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940227-500 1x 500 µL
Milk Fat Globulin (MFG-06), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040173-100 1x 100 µL
CD45 / LCA (136-4B5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details